Literature DB >> 24863339

NetTepi: an integrated method for the prediction of T cell epitopes.

Thomas Trolle1, Morten Nielsen.   

Abstract

Multiple factors determine the ability of a peptide to elicit a cytotoxic T cell lymphocyte response. Binding to a major histocompatibility complex class I (MHC-I) molecule is one of the most essential factors, as no peptide can become a T cell epitope unless presented on the cell surface in complex with an MHC-I molecule. As such, peptide-MHC (pMHC) binding affinity predictors are currently the premier methods for T cell epitope prediction, and these prediction methods have been shown to have high predictive performances in multiple studies. However, not all MHC-I binders are T cell epitopes, and multiple studies have investigated what additional factors are important for determining the immunogenicity of a peptide. A recent study suggested that pMHC stability plays an important role in determining if a peptide can become a T cell epitope. Likewise, a T cell propensity model has been proposed for identifying MHC binding peptides with amino acid compositions favoring T cell receptor interactions. In this study, we investigate if improved accuracy for T cell epitope discovery can be achieved by integrating predictions for pMHC binding affinity, pMHC stability, and T cell propensity. We show that a weighted sum approach allows pMHC stability and T cell propensity predictions to enrich pMHC binding affinity predictions. The integrated model leads to a consistent and significant increase in predictive performance and we demonstrate how this can be utilized to decrease the experimental workload of epitope screens. The final method, NetTepi, is publically available at www.cbs.dtu.dk/services/NetTepi .

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24863339     DOI: 10.1007/s00251-014-0779-0

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  37 in total

Review 1.  SYFPEITHI: database for MHC ligands and peptide motifs.

Authors:  H Rammensee; J Bachmann; N P Emmerich; O A Bachor; S Stevanović
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

Review 2.  CD8+ T cell effector mechanisms in resistance to infection.

Authors:  J T Harty; A R Tvinnereim; D W White
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  NetMHCcons: a consensus method for the major histocompatibility complex class I predictions.

Authors:  Edita Karosiene; Claus Lundegaard; Ole Lund; Morten Nielsen
Journal:  Immunogenetics       Date:  2011-10-20       Impact factor: 2.846

Review 4.  Major histocompatibility complex class I binding predictions as a tool in epitope discovery.

Authors:  Claus Lundegaard; Ole Lund; Søren Buus; Morten Nielsen
Journal:  Immunology       Date:  2010-05-26       Impact factor: 7.397

5.  NetMHCstab - predicting stability of peptide-MHC-I complexes; impacts for cytotoxic T lymphocyte epitope discovery.

Authors:  Kasper W Jørgensen; Michael Rasmussen; Søren Buus; Morten Nielsen
Journal:  Immunology       Date:  2014-01       Impact factor: 7.397

6.  NetCTLpan: pan-specific MHC class I pathway epitope predictions.

Authors:  Thomas Stranzl; Mette Voldby Larsen; Claus Lundegaard; Morten Nielsen
Journal:  Immunogenetics       Date:  2010-04-09       Impact factor: 2.846

7.  A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection.

Authors:  Erika Assarsson; John Sidney; Carla Oseroff; Valerie Pasquetto; Huynh-Hoa Bui; Nicole Frahm; Christian Brander; Bjoern Peters; Howard Grey; Alessandro Sette
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

8.  NetMHCpan, a method for MHC class I binding prediction beyond humans.

Authors:  Ilka Hoof; Bjoern Peters; John Sidney; Lasse Eggers Pedersen; Alessandro Sette; Ole Lund; Søren Buus; Morten Nielsen
Journal:  Immunogenetics       Date:  2008-11-12       Impact factor: 2.846

9.  POPISK: T-cell reactivity prediction using support vector machines and string kernels.

Authors:  Chun-Wei Tung; Matthias Ziehm; Andreas Kämper; Oliver Kohlbacher; Shinn-Ying Ho
Journal:  BMC Bioinformatics       Date:  2011-11-15       Impact factor: 3.169

10.  NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11.

Authors:  Claus Lundegaard; Kasper Lamberth; Mikkel Harndahl; Søren Buus; Ole Lund; Morten Nielsen
Journal:  Nucleic Acids Res       Date:  2008-05-07       Impact factor: 16.971

View more
  18 in total

1.  Predicted MHC peptide binding promiscuity explains MHC class I 'hotspots' of antigen presentation defined by mass spectrometry eluted ligand data.

Authors:  Emma Christine Jappe; Jens Kringelum; Thomas Trolle; Morten Nielsen
Journal:  Immunology       Date:  2018-03-08       Impact factor: 7.397

2.  In silico and cell-based analyses reveal strong divergence between prediction and observation of T-cell-recognized tumor antigen T-cell epitopes.

Authors:  Julien Schmidt; Philippe Guillaume; Danijel Dojcinovic; Julia Karbach; George Coukos; Immanuel Luescher
Journal:  J Biol Chem       Date:  2017-05-23       Impact factor: 5.157

Review 3.  Computational approaches for characterizing the tumor immune microenvironment.

Authors:  Candace C Liu; Chloé B Steen; Aaron M Newman
Journal:  Immunology       Date:  2019-10       Impact factor: 7.397

4.  Evaluating performance of existing computational models in predicting CD8+ T cell pathogenic epitopes and cancer neoantigens.

Authors:  Paul R Buckley; Chloe H Lee; Ruichong Ma; Isaac Woodhouse; Jeongmin Woo; Vasily O Tsvetkov; Dmitrii S Shcherbinin; Agne Antanaviciute; Mikhail Shughay; Margarida Rei; Alison Simmons; Hashem Koohy
Journal:  Brief Bioinform       Date:  2022-05-13       Impact factor: 13.994

Review 5.  Current tools for predicting cancer-specific T cell immunity.

Authors:  David Gfeller; Michal Bassani-Sternberg; Julien Schmidt; Immanuel F Luescher
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

Review 6.  Computational genomics tools for dissecting tumour-immune cell interactions.

Authors:  Hubert Hackl; Pornpimol Charoentong; Francesca Finotello; Zlatko Trajanoski
Journal:  Nat Rev Genet       Date:  2016-07-04       Impact factor: 53.242

7.  Analyzing the effect of peptide-HLA-binding ability on the immunogenicity of potential CD8+ and CD4+ T cell epitopes in a large dataset.

Authors:  Shufeng Wang; Jintao Li; Xiaoling Chen; Li Wang; Wei Liu; Yuzhang Wu
Journal:  Immunol Res       Date:  2016-08       Impact factor: 4.505

Review 8.  Identification of neoantigens for individualized therapeutic cancer vaccines.

Authors:  Franziska Lang; Barbara Schrörs; Martin Löwer; Özlem Türeci; Ugur Sahin
Journal:  Nat Rev Drug Discov       Date:  2022-02-01       Impact factor: 112.288

Review 9.  Ebolavirus comparative genomics.

Authors:  Se-Ran Jun; Michael R Leuze; Intawat Nookaew; Edward C Uberbacher; Miriam Land; Qian Zhang; Visanu Wanchai; Juanjuan Chai; Morten Nielsen; Thomas Trolle; Ole Lund; Gregory S Buzard; Thomas D Pedersen; Trudy M Wassenaar; David W Ussery
Journal:  FEMS Microbiol Rev       Date:  2015-07-14       Impact factor: 16.408

10.  CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany.

Authors:  Mustafa Diken; Sebastian Boegel; Christian Grunwitz; Lena M Kranz; Kerstin Reuter; Niels van de Roemer; Fulvia Vascotto; Mathias Vormehr; Sebastian Kreiter
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.